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Accumulated evidence has suggested that BMP pathways play critical roles during mammalian cardiogenesis and impairment of BMP signaling
may contribute to human congenital heart diseases (CHDs), which are the leading cause of infant morbidity and mortality. Alk3 encodes a BMP
specific type I receptor expressed in mouse embryonic hearts. To reveal functions of Alk3 during atrioventricular (AV) cushion morphogenesis and to
overcome the early lethality of Alk3−/− embryos, we applied a Cre/loxp approach to specifically inactivate Alk3 in the endothelium/endocardium. Our
studies showed that endocardial depletion of Alk3 severely impairs epithelium–mesenchymal–transformation (EMT) in the atrioventricular canal
(AVC) region; the number of mesenchymal cells formed in Tie1-Cre;Alk3loxp/loxp embryos was reduced to only∼20% of the normal level from both
in vivo section studies and in vitro explant assays. We showed, for the first time, that in addition to its functions on mesenchyme formation, Alk3 is
also required for the normal growth/survival of AV cushion mesenchymal cells. Functions of Alk3 are accomplished through regulating expression/
activation/subcellular localization of multiple downstream genes including Smads and cell-cycle regulators. Taken together, our study supports the
notion that Alk3-mediated BMP signaling in AV endocardial/mesenchymal cells plays a central role during cushion morphogenesis.
© 2006 Elsevier Inc. All rights reserved.Keywords: Alk3; Atrioventricular cushion; BMP; Cardiogenesis; Congenital heart diseases; Epithelial–mesenchymal transformation (EMT)Introduction
CHDs are the leading cause of infant morbidity and
mortality, occurring in as many as 1% of newborns (Hoffman,
1995; Hoffman and Kaplan, 2002). The most common CHDs
are caused by maldevelopment of septation and valvulogenesis.
EMT in the AVC and outflow tract (OFT) regions is a critical
process regulating initial valve formation where a subpopula-
tion of endocardial cells invade the extracellular matrix as the
result of regional interaction between the myocardium and⁎ Corresponding authors. H.S. Baldwin is to be contacted at Division of
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doi:10.1016/j.ydbio.2006.08.004endocardium (Armstrong and Bischoff, 2004; Barnett and
Desgrosellier, 2003; Schroeder et al., 2003). These mesenchy-
malized cushions serve as the primordia of valves and septa and
are developed into mature structures through complicated
remodeling processes. The molecular and cellular mechanisms
underlying cushion morphogenesis and their potential clinical
significance have received great attention.
Results from numerous studies have established that EMT
relies on proper responses of the underlying endocardial cells to
the stimulating signal molecules released from the overlying
myocardium in the AVC region. Many signaling molecules
including TGFβ, Notch, Wnt, EGF and VEGF have been shown
with experimental evidence to be involved in EMT (Armstrong
and Bischoff, 2004; Barnett and Desgrosellier, 2003; Schroeder et
al., 2003). More recent studies have suggested that Bmp2 plays a
critical role in activating EMTin theAVC region. In vitro collagen
gel assays with avian AVC explants showed that Bmp2 can
substitute for the overlying myocardium and is sufficient to
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antagonist, noggin, inhibits EMT (Sugi et al., 2004). Furthermore,
the most recent mouse genetic studies showed that myocardial
inactivation of Bmp2 blocks formation of AV cushion mesenchy-
mal cells (Ma et al., 2005; Rivera-Feliciano and Tabin, 2006).
After mesenchymal cells are formed through EMT, AV
cushions undergo complicated remodeling processes, which
include cell migration, proliferation, apoptosis and differentiation,
to form mature septal and valvular structures. Compared to the
process of EMT, fewer studies have aimed at revealing the mole-
cular and cellular mechanisms underlying cushion remodeling
after EMT. Some published studies (i.e. Gaussin et al., 2005;
Gaussin et al., 2002; Tevosian et al., 2000) showed that disruption
of the integrity of myocardium also causes structural defects of
septa and valves, suggesting that cushion remodeling at later
stages also relies on proper communication between the myocar-
dium and the mesenchyme/endocardium. We showed previously
that myocardial Bmp4 is dispensable for EMT, but is required for
normal proliferation of AV cushion mesenchymal cells, as
inactivation of Bmp4 in the myocardium causes the atrioven-
tricular canal defect (AVCD) (Jiao et al., 2003). However, it is
unclear from this study whether Bmp4 released from the myocar-
dium acts directly on AV cushion mesenchymal cells to stimulate
their growth or if the function of Bmp4 is mediated through cer-
tain unknown signalingmolecules released from themyocardium.
BMP ligands belong to the TGFβ superfamily of cytokines
(Hogan, 1996; Kishigami and Mishina, 2005; von Bubnoff and
Cho, 2001), and their activities are mediated through hetero-
dimeric complexes of type I and type II serine/threonine kinase
receptors (Kishigami and Mishina, 2005; Shi and Massague,
2003; von Bubnoff and Cho, 2001). After formation of the
receptor/ligand complex, the type II receptor will phosphorylate
the type I receptor, which in turn phosphorylates particular
members of the Smad family of cytoplasmic proteins. The
phosphorylated (activated) Smad proteins will then translocate
into the nucleus to function as transcriptional modulators (Shi
and Massague, 2003; von Bubnoff and Cho, 2001). Among the
three type I receptors (Alk2, 3, 6) that can mediate BMP signals
(de Caestecker, 2004; Kishigami andMishina, 2005), Alk6 is not
expressed in embryonic hearts (Dewulf et al., 1995; Jiao et al.,
unpublished data), and is thus unlikely to play a direct role
during cardiogenesis. A previous study showed that in Tie2-Cre;
Alk2loxp/loxp embryonic hearts, the number of mesenchymal cells
in the superior cushion is decreased to ∼40% of the normal
level, while that in the inferior cushion is ∼65% of the normal
level, indicating that Alk2 is required for normal AV cushion
morphogenesis (Wang et al., 2005). Alk3 is another BMP type I
receptor expressed in embryonic hearts. Alk2 and Alk3 appear to
preferentially mediate different BMP ligands. The primary BMP
ligands binding to Alk2 are Bmp5, 6, 7, while Alk3 primarily
mediates Bmp2, 4 signaling although it may also mediate
signaling through other BMP ligands (de Caestecker, 2004 and
ref. therein). Therefore, Alk3may play a distinct role from that of
Alk2 during cardiogenesis. Consistent with this idea, myocardial
inactivation of Alk3 causes embryonic lethality due to heart
failure (Gaussin et al., 2002), while myocardial Alk2 appears to
be dispensable for heart formation (Wang et al., 2005).This report continues our study of functions of BMP signaling
during AV cushionmorphogenesis. To complement our previous
approach using myocardial deletion of a gene encoding a BMP
ligand (Bmp4) (Jiao et al., 2003), we specifically inactivated
Alk3 in endothelial cells by breeding Tie1-Cre and Alk3loxp/loxp
mice. Detailed characterization of Tie1-Cre;Alk3loxp/loxp has led
to the conclusion that endocardial/mesenchymal Alk3 plays
critical roles during AV cushion morphogenesis.
Materials and methods
Mouse and embryo manipulations
All procedures are approved by the Institutional Animal Care and Use
Committee at Vanderbilt University and the University of Alabama. The
Tie1-Cre mice (Gustafsson et al., 2001) were crossed with the Alk3loxp/loxp
mice (Mishina et al., 2002) to specifically inactivate Alk3 in endothelial cells (see
Results for detailed breeding strategy). In performing conditional gene inacti-
vation experiments, we always used the male Tie1-cre;Alk3loxp/+ mice to cross
with female Alk3loxp/loxp mice. To perform cell lineage assays, the Alk3loxp/loxp
mice were crossed with the R26Rmice (Soriano, 1999) (from the Jackson Lab) to
acquire the Alk3loxp/+;R26R mice, which were then intercrossed to generate the
Alk3loxp/loxp;R26R/R26R mice. Mouse genotyping, embryo dissection, section-
ing, HE staining andX-gal stainingwere performed as described previously (Jiao
et al., 2003; Jiao et al., 2002).
In vitro collagen gel assay
The in vitro collagen gel assays were performed as described previously
(Camenisch et al., 2002).
TUNEL assays and non-radioactive section in situ hybridization
analysis
TUNEL assays were performed using the “Dead End Colormetric TUNEL
system” (Promega) following manufacturer's instructions. Non-radioactive
section in situ hybridization analysis was performed as described previously
(Grapin-Botton et al., 2001).
Immunostaining studies
Immunofluorescence studies were performed as described previously (Jiao
et al., 2003). cy2 conjugated secondary antibodies were used for visualization of
the signal. Total nuclei were visualized with Propidiumiodide or DAPI staining.
Samples were examined with the Leica HC fluorescent microscope equipped
with a RT SLIDER digital camera. Immunohistochemistry studies were
performed using the Envision+ system (DAKOcytomation) following manufac-
turer's instructions. Sections were counter stained briefly with Hematoxylin.
The primary antibodies used in this study include antibodies recognizing cyclin
D1 (BD Biosciences), α-smooth muscle actin (Sigma), Caspase 3 (Cell
Signaling), p21 (Cell Signaling), phospho-H3 (UpState), phospho-Smad1,5,8
(Cell Signaling), phospho-Smad2,3 (Cell Signaling), NFATc1 (BD Biosciences)
and Msx1/2 (Iowa Hybridoma Bank).
Results
A Tie1-Cre mouse line efficiently inactivates Alk3 in endothelial
cells of mouse embryos
To overcome the early embryonic lethality of Alk3−/− mice
(Mishina et al., 1995), and to reveal in vivo functions of Alk3
during AV cushion morphogenesis, we decided to specifically
inactivate Alk3 in the endothelium/endocardium using Tie1-Cre
Fig. 1. Efficient inactivation of Alk3 by Tie1-Cre. (A–C) To determine the efficiency and specificity of recombination induced by Tie1-Cre, the Tie1-Cre mice were
crossed with R26R mice. Embryos isolated from the cross were whole-mount stained with X-gal. LacZ positive cells were observed in the Tie1-Cre;R26R embryo
(E9.5) but not in its littermate of a Tie1-Cre−;R26R embryo (A). X-gal stained Tie1-Cre;R26R embryos at E9.5 (B) and E10.5 (C) were sagittally sectioned and
counterstained with eosin. (D–G) Non-isotope section in situ hybridization analysis was performed with a probe corresponding to the second exon of Alk3 on mutant
(D) and control (E, F) embryo sections. The signal of Alk3 was specifically reduced in the endocardial/mesenchymal cells of the mutant embryo (D) compared to the
control embryo (E, F). The red arrows in panels E and F indicate the cushion mesenchymal cells. Panel G shows the result of using the sense probe as a negative
control. A: atrium, cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3loxp/+, V: ventricle.
Table 1
Summary of initial cross between Tie1cre;Alk3loxp/+ mice and Alk3loxp/loxp mice
Genotype # of embryos # of expected
Tie1cre+; Alk3loxp/+ 22 11
Tie1cre+; Alk3loxp/loxp 1 11
Tie1cre−; Alk3loxp/+ 1 11
Tie1cre−; Alk3loxp/loxp 20 11
Total 44 44
Embryos were isolated between E9.5 and E10.5 from total 5 litters.
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Tie1-Cre induces a high level of recombination of target genes
specifically in endothelial cells of mouse embryos (Gustafsson
et al., 2001), we crossed Tie1-Cre mice with Rosa26 reporter
(R26R; Soriano, 1999) mice, and stained the embryos with X-
gal. The Tie1-Cre-mediated recombination at the R26 locus
could be readily detected at E9.5 from whole-mount staining
(Fig. 1A). Section studies confirmed that recombination occurs
specifically in endothelial cells, including endocardial cells
(Figs. 1B, C). Almost all AV cushion mesenchymal cells, which
are derived from endocardial cells through EMT, were
positively stained with X-gal, indicating that Tie1-Cre induces
recombination of a target gene before EMT occurring in the
AVC. To directly evaluate the recombination efficiency induced
by Tie1-Cre at the Alk3 locus, we performed section in situ
hybridization analysis with a probe corresponding to the exon 2
of Alk3, which is flanked with two floxp sites in the Alk3loxp
allele and will be removed upon Cre-mediated recombination
(Mishina et al., 2002). Alk3 exon 2 is undetectable in the
endocardial/mesenchymal cells of mutant embryos (Tie1-Cre;
Alk3loxp/loxp), while its expression in other embryonic regions
including the myocardium is not affected compared to control
embryos (Figs. 1D vs. E). The RNA signals of Alk3 could also
be detected in AV cushion mesenchymal cells at a later stage
(Fig. 1F), suggesting that Alk3 may also play a role during
remodeling of AV cushions after EMT. Thus, we concluded that
Tie1-Cre efficiently recombines the Alk3 locus in the endo-
cardial and mesenchymal cells of conditional knockout (cko)
embryos.
Endothelial inactivation of Alk3 causes embryonic lethality
To perform conditional gene inactivation experiments, we
first mated Tie1-Cre;Alk3+/+ mice with Alk3loxp/loxp mice toobtain Tie1-Cre;Alk3loxp/+ mice, which were then crossed with
Alk3loxp/loxp mice. To our surprise, the distribution of genotypes
of embryos (at E9.5∼E10.5) differed significantly from the
expected ratio (P<0.05, χ2 test) (Table 1). While the early
embryonic lethality might cause the reduced number of Tie1-
Cre+;Alk3loxp/loxp embryos, it cannot explain the dramatically
reduced number of Tie1-Cre−;Alk3loxp/+ embryos. In fact, the
observed distribution is consistent with the idea that the Tie1-
Cre transgene is closely linked with the Alk3 allele, and thus
Tie1-Cre fails to randomly segregate from the wild type allele
of Alk3 during gametogenesis in Tie1-Cre;Alk3loxp/+ mice. We
then performed a test cross by mating Tie1-Cre;Alk3loxp/+ mice
with wild type (Tie1-cre−;Alk3+/+) mice. Results from the test
cross confirmed the genetic linkage between Tie1-Cre and Alk3
with the recombination frequency between them calculated as
∼6% (Supplementary Table 1). The Tie1-cre;Alk3loxp/+ mice
obtained from the test cross, in which the Tie1-Cre transgene is
linked with the Alk3loxp allele (as indicated with the “under-
line”), but not with the Alk3+ allele, were used in the following
conditional gene inactivation experiments.
We did not recover any Tie1-Cre;Alk3loxp/loxp neonates from
the breeding between Tie1-Cre;Alk3loxp/+ mice and Alk3loxp/loxp
mice (total of 7 litters), suggesting that endothelial inactivation
of Alk3 results in embryonic lethality. To determine the stage at
Fig. 2. Endothelial inactivation of Alk3 causes embryonic lethality. (A) The chart shows the percentage of living Tie1-Cre;Alk3loxp/loxp embryos isolated at various
stages from the cross between Tie1-Cre;Alk3loxp/+ mice and Alk3loxp/loxp mice. The expected ratio is 47% due to the genetic linkage (see Results). The total numbers of
embryos examined are 54, 85, 45, 35 and 29 for E9.5, E10.5, E11.5, E12.5 and≥E13.5, respectively. “≥E13.5” refers to the stages beyond E13.5. (B) The majority of
Tie1-Cre;Alk3loxp/loxp embryos isolated at E11.5 do not show obvious gross abnormalities. (C) Very few mutant embryos can survive to the E12.5 stage. Most of them
were arrested at approximately the E11.5 stage with internal hemorrhages. (D) A Tie1-Cre;Alk3loxp/loxp;R26R embryo at E11.5 was stained with X-gal and cross-
sectioned. The red arrow points to the area where some red blood cells were leaked out from a blood vessel, whose endothelial wall was stained blue. cko (B, C): Tie1-
Cre;Alk3loxp/loxp, cko (D): Tie1-Cre;Alk3loxp/loxp;R26R, ctrl: Alk3loxp/+.
Fig. 3. Failure of cellularization of AV cushions in Tie1-Cre;Alk3loxp/loxp embryonic hearts. (A–D) Control (A, C) andmutant (B, D) embryos isolated at E9.5 (A, B) and
E10.5 (C, D) were sagittally sectioned andHE stained. The AV cushionmesenchymal cells inmutant hearts were visibly reduced compared to those in control hearts. (E)
To quantitatively determine the extent of reduction in AV cushion mesenchymal cells caused by endocardial inactivation of Alk3, the total number of mesenchymal cells
was determined by counting all sections covering the AVC region. The number of control hearts was artificially set as 100%.Data were averaged from 3 embryos of each
genotype. The error bar indicates the StandardDeviation (SD). The average numbers of AV cushionmesenchymal cells in control embryos are 968 and 4648 for E9.5 and
E10.5, respectively, and 116 and 738 for E9.5 and E105, respectively, in mutant embryos. A potential problem could be caused by overlapping cells in adjacent sections.
We thus counted mesenchymal cells in every other sections, and obtained essentially the same result (data not shown). (F, F′, G, G′) Tie1cre;Alk3loxp/lxop;R26R embryos
at E9.5 (F, F′) and E10.5 (G, G′) were stainedwithX-gal, sagittally sectioned and counterstainedwith eosin. Panels F′ andG′ correspond to the boxed regions of panels F
and G, respectively. Almost all mesenchymal cells were positively stained with X-gal, suggesting that they are derived from endocardial cells. The red arrows in panels
F′ and G′ indicate mesenchymal cells. A: atrium, cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3loxp/+, V: ventricle, *P<0.01 (Student's t test).
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Fig. 4. Alk3 is required for EMT in vitro. (A, B) In vitro collagen gel analysis
was performed with control (A) and mutant (B) AV explants at E9.25 as
described in (Camenisch et al., 2002). Compared to control explants, the
endocardium of mutant explants did not expand on the gel surface and fewer
mesenchymal cells are formed. Examples of transformed cells (elongated and
separated from other cells) were indicated with red arrows. (C, D) To further
confirm the reduction of transformed cells in mutant explants, immunofluor-
escence studies were performed with an antibody against α-smooth muscle actin
(α-SMA, green). Total nuclei were visualized with Propidiumiodide staining
(red). Fewer α-SMA positive cells were observed in mutant explants (D) than in
controls (C). The dotted areas in panels C and D indicate the origin of the
explants. (E) The number of transformed cells in both control (n=7) and mutant
explants (n=4) was counted under a light microscope. Data were shown as
mean±SD. cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3loxp/+, *P<0.01 (Student's
t test).
280 L. Song et al. / Developmental Biology 301 (2007) 276–286which embryonic death occurs, we isolated embryos from E9.5
to E19.5. As shown in Fig. 2A, the number of observed cko
embryos at E9.5 and E10.5 is not significantly different from the
expected ratio (47%, due to genetic linkage). ∼75% of mutant
embryos survive to the E11.5 stage. Most of them (∼70%) grew
normally (Fig. 2B), with some (∼30%) showing growth
retardation, which were excluded from further characterization
studies. Very few mutant embryos could survive to E12.5. The
dead animals at this stage typically showed growth arrest (at
∼E11.5) and internal hemorrhages (Fig. 2C). In certain
sections of E11.5 mutant embryos, we observed that some
red blood cells were leaked out from vessels (Fig. 2D),
presumably due to abnormal apoptosis of vessel endothelial
cells (see below). No live mutant embryos could be recovered
beyond the E13.5 stage.
Endocardial Alk3 is required for normal cellularization of AV
cushions
To determine potential functions of Alk3 during AV cushion
morphogenesis, we compared mutant embryos together with
their littermates as controls for detailed histological examination.
Only live embryos without obvious gross abnormalities were
included for further analysis to minimize the possibility that the
observed endocardial defects were secondary to general growth
retardation. The size of AV cushions of mutant embryos at E9.5
are comparable to that of controls (Figs. 3A, B), suggesting that
expansion of extracellular matrix between the myocardium and
the endocardium at the AVC region occurs normally in mutant
hearts. A dramatic reduction in the number of AV cushion
mesenchymal cellswasobserved inmutants compared tocontrols
(Figs. 3A–D). We then performed quantification analysis to
further determine towhat extent thenumberofmesenchymalcells
is reduced by endocardial inactivation of Alk3. The total number
of mesenchymal cells in mutant embryos is reduced to less than
18% of that of controls at both E9.5 and E10.5 (Fig. 3E).
To address whether the remaining AV cushion mesenchymal
cells in mutant embryos were derived from endocardial cells
rather than from other embryonic origins (i.e. neural crest cells)
or were derived via unknown compensatory mechanisms, we
carried out cell lineage analysis by performing the conditional
gene inactivation experiments on the R26R background. As
shown in Figs. 3F–G′, despite the obvious reduction in the total
number of mesenchymal cells in mutant embryos (comparing to
Figs. 1B, C), almost all AV cushion mesenchymal cells were
lacZ positive, indicating that they are derived from the
endocardium as were the controls (Figs. 1B, C).
Alk3 is required for EMT
The dramatic reduction in the number of cushion mesenchy-
mal cells in mutant embryonic hearts could be due to a failure in
EMT, an increase in apoptosis and/or a decrease in cell
proliferation. To directly test whether Alk3 is required for
normal EMT, we performed in vitro collagen gel analysis,
which was first established to study EMT in the AVC region of
chicken embryonic hearts (Bernanke and Markwald, 1982),and has been recently adapted to study mouse embryos (e.g.
Camenisch et al., 2002; Sugi et al., 2004). In contrast to the
well formed mesenchymal cells in control explants, the
endocardial cells in mutant explants did not undergo expansion,
and only a few mesenchymal cells were evident (Figs. 4A vs.
B). This result was further confirmed with immunofluorescent
studies using an antibody against α-smooth muscle actin (Figs.
4C, D), which is widely used as a cushion mesenchymal
marker (e.g. Sugi et al., 2004). Quantification analysis indicates
that the number of transformed mesenchymal cells in mutant
explants was reduced to about ∼25% of that of controls (Fig.
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normal EMT.
Alk3 is required for proper survival and proliferation of
endocardial/mesenchymal cells
To address whether increased cell apoptosis also contributes
to the AV cushion defect observed in mutant embryos, we
performed a TUNEL assay. No dead cells were evident in AV
cushions of either control or mutant embryonic hearts at E9.5
(data not shown). At E10.5, very few apoptotic cells were
identified in the AV cushions of control hearts, while more were
found in mutant hearts (Figs. 5A, B, B′). To further verify that
cell death is caused by apoptosis rather than necrosis, we
immunostained sections of control and mutant embryos with an
antibody against cleaved Caspase 3. Quantification assays
revealed that apoptotic cells were significantly increased in
mutant samples (Figs. 5C, D, D′, E) (P<0.01). In addition to the
AVC region, apoptotic cells were also present in endothelial
cells of blood vessels in E10.5 mutant embryos, while at this
stage, very few, if any, Caspase 3 positive cells were found in
control endothelial cells (Figs. 5F vs. G). The death of
endothelial cells would disrupt the integrity of blood vessels,
resulting in hemorrhages, and thus contribute to embryonic
lethality of cko embryos.
In the next experiment, we stained embryo sections with an
anti-phosopho-H3 antibody to examine the potential prolifera-
tion defect in endocardial/mesenchymal cells of mutant
embryos (Fig. 6). The percentage of phospho-H3 positiveFig. 5. Alk3 is required for normal survival of endothelial/mesenchymal cells. (A, B
performed as described in Materials and methods. Dead cells were rarely observed in
embryos (B). The arrows indicate examples of apoptotic cells, which can be found in b
panel B. (C–E) To further confirm if cell apoptosis is increased by endocardial/mesenc
anti-Caspase 3 antibody (green), and total nuclei were visualized with Propidiumiodid
controls (E10.5, C), but were often observed in of mutant hearts (D). Examples of Cas
the blood cells in the heart chamber. Panel D′ corresponds to the boxed area of panel D
nuclei were counted for each embryo. Error bars indicate SD. (F, G) Caspase 3 positi
were present in mutant embryos (G). The white arrows in panel G indicate exampl
myocardium, *P<0.01 (Student's t test).cells is significantly reduced in mutant embryos (P<0.01),
suggesting that Alk3 is required for normal proliferation of
endocardial and cushion mesenchymal cells of the AVC
region.
Activation of BMP Smads, but not TGFβ Smads, is specifically
reduced in endocardial/mesenchymal cells of the AVC of
mutant embryos
Smad1,5,8 are BMP Smads that are activated (phosphory-
lated) upon BMP stimulation (de Caestecker, 2004; Massague et
al., 2005; Shi and Massague, 2003). To determine the effects of
loss of Alk3 on BMP downstream signaling, we performed
immunohistochemistry analysis using an antibody specifically
recognizing phosphorylated Smad1,5,8 (Figs. 7A–D). In
control embryos, ∼95% of endocardial/mesenchymal cells at
the AVC region were positively stained with the antibody, while
in mutant hearts, the number of positively stained cells is
reduced to ∼60%, indicating that BMP signaling was reduced
in endocardial/mesenchymal cells of cko embryos. The
remaining phospho-Smad1,5,8 positive cells in mutant hearts
were probably due to the persistent and potentially compensa-
tory signaling from other type I receptors like Alk2. We did not
observe evident changes of active BMP Smads in cardiomyo-
cytes of mutant hearts, suggesting that the reduction of BMP
signaling activity is specific to endocardial/mesenchymal cells.
We further tested whether activation of TGFβ Smads (Smad2,3)
was also affected by loss of endocardial Alk3. As shown in Figs.
7E–H, activated Smad2,3 were observed in the majority of) To determine the requirement of Alk3 on cell survival, TUNEL assays were
AV cushions of control embryos (E11.5, A) but were evident in those of mutant
oth the endocardial layer and cushions. Panel B′ corresponds to the boxed area of
hymal inactivation of Alk3, immunofluorescence studies were performed with an
e staining (red). Caspase 3 positive nuclei were extremely rare in AV cushions of
pase 3 positive nuclei are indicated with white arrows. The green arrow indicates
. In panel E, data were averaged from four independent embryos, and at least 400
ve nuclei were rarely found in vessel endothelial cells of controls (E10.5, F), but
es of apoptotic cells. cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3loxp/+, c: cushion, m:
Fig. 6. Reduction of cell proliferation in AV cushions of mutant embryonic hearts.
(A–C) Embryo sections of controls (A) and mutants (B) were immunostained with
an anti-phospho-H3 antibody (green) to identify proliferating cells and with
Propidiumiodide to visualize total nuclei (red). The white arrows indicate
phospho-H3 positive nuclei of endocardial cells or AV cushion mesenchymal cells.
Phospho-H3 positive nuclei were also observed in the myocardium. In panel C,
data were averaged from four embryos of each genotype, and at least 400 nuclei
were counted for each embryo. Error bars indicate SD. cko: Tie1-Cre;Alk3loxp/loxp,
ctrl: Alk3loxp/+, c: cushion, m: myocardium, *P<0.01 (Student's t test).
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embryonic hearts without any obvious differences. Thus, we
concluded that endothelial inactivation of Alk3 specificallyFig. 7. Endocardial inactivation of Alk3 specifically decreases the level of activated
performed on mutant (A, B) and control (C, D) embryo sections (E10.0) with a ph
Samples were quickly counterstained with Hematoxylin (blue). The phosphor-Sma
mutant AV cushions than in controls. Panels B and D correspond to the boxed regio
performed on mutant (E, F) and control (G, H) embryo sections (E10.0) with a phosph
were counterstained with Hematoxylin (blue). Most endocardial/mesenchymal cells
control AV cushions without obvious difference. Panels F and H correspond to the b
examples of phospho-Smads negative nuclei. cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3lodecreases the activation of BMP Smads in endocardial/
mesenchymal cells. This result is different from endothelial
inactivation of Alk2; in Tie2-Cre;Alk2loxp/loxp AV cushions,
both activated BMP and TGFβ Smads were dramatically
reduced (Wang et al., 2005).
Expression ofmultiples genes was altered in Tie1-Cre;Alk3loxp/loxp
embryonic hearts
To further characterize the molecular pathology of the Tie1-
Cre;Alk3loxp/loxp embryos, we examined expression of multiple
genes with immunostaining analysis. NFATc1 is specifically
expressed in the endocardium but not other areas of vascular
endothelial cells, and is required for proper cushion morpho-
genesis during cardiogenesis (Chang et al., 2004; de la Pompa et
al., 1998; Ranger et al., 1998; Zhou et al., 2005). It was recently
reported that expression of NFATc1 was reduced in Nkx2.5-
Cre;Bmp2loxp/lox embryos (Ma et al., 2005). However, our study
does not reveal abnormal expression of NFATc1 in Tie1-Cre;
Alk3loxp/loxp embryos (Figs. 8A–D). Therefore, the reduction of
NFATc1 expression in Bmp2 conditional knockout mice may be
due to the failure in specifying the AV myocardium (Ma et al.,
2005). Msx1/2 are known BMP target genes that are expressed
in the endocardial/mesenchymal cells of AV cushions during
EMT (Abdelwahid et al., 2002; Bei et al., 2000; Bei and Maas,
1998; Gitler et al., 2003; Hussein et al., 2003), and the level of
Msx1 transcripts was reduced in both Nkx2.5-Cre;Bmp2loxp/loxp
and Tie2-Cre;Alk2loxp/− embryos (Ma et al., 2005; Wang et al.,
2005). We studied the collective expression of Msx1/2 using an
antibody recognizing both proteins. As shown in Figs. 8E–H,
expression of Msx1/2 was obviously reduced in the AV
cushion cells of Tie1cre;Alk3loxp/loxp embryos, suggesting thatBMP Smads but not TGFβ Smads. (A–D) Immunohistochemistry analysis was
ospho-Smad1,5,8 (activated form of BMP Smads) specific antibody (brown).
d1,5,8 negative nuclei (indicated with red arrowheads) were more abundant in
ns of panels A and C, respectively. (E–H) Immunohistochemistry analysis was
o-Smad2,3 (activated form of TGFβ Smads) specific antibody (brown). Samples
were positively stained with the phospho-Smad2,3 antibody in both mutant and
oxed regions of panels E and G, respectively. Arrowheads in all panels indicate
xp/+, c: cushion, e: endocardium, m: myocardium.
Fig. 8. Expression of multiple genes is altered by endocardial inactivation of Alk3. (A–D) Sections of mutant (A, B) and control (C, D) embryos (E10.5) were
immunostained with an antibody against NFATc1 (green, A, C), and total nuclei were visualized with DAPI staining (blue, B, D). No obvious reduction in expression of
NFATc1 was observed in mutant sections. The red blood cells retained in heart chambers showed auto-fluorescence as indicated with the white arrow in panel A. (E–H)
Immunofluorescence studies were performed with an anti-Msx1/2 antibody (green). Expression of Msx1/2 in mutant hearts (E, F) was noticeably reduced compared to
control hearts (G, H). (I, J) Immunohistochemistry analysis was performed with an anti-p21 antibody (brown), and sections were counter stained with Hematoxylin
(blue). p21 positive nuclei were evident in mutant AV cushions (I) but absent in controls (J). The arrowheads in panel I indicate examples of p21 positive nuclei. (K–O)
Mutant (K, L) and control (M,N) sectionswere immunostainedwith an anti-cyclinD1 antibody (green, K,M), and total nuclei were visualizedwith DAPI staining (blue,
L, N). The arrowheads in panel K represent examples of cells without cyclinD1 localized in nuclei. Quantitative analysis reveals that the percentage of cyclinD1 positive
nuclei in mutant AV cushions was significantly reduced compared to that in controls (O). cko: Tie1-Cre;Alk3loxp/loxp, ctrl: Alk3loxp/+, c: cushion, e: endocardium, m:
myocardium, *P<0.05 (Student's t test).
283L. Song et al. / Developmental Biology 301 (2007) 276–286expression of Msx1/2 is down-regulated by endocardial
depletion of Alk3.
To gain further insight into the mechanism of Alk3 regulation
of proliferation and survival of AV cushion endocardial/
mesenchymal cells, we performed immunohistochemistry
analysis using an antibody against p21(Cip1/Waf1), which
inhibits cell-cycle-dependent kinase (CDK) of a broad spectrum
when present in nuclei (Coqueret, 2003; Gartel and Tyner, 2002;
Semczuk and Jakowicki, 2004; Swanton, 2004). We did not
observe any p21 positive nuclei in AV cushions of either mutant
or control hearts at E9.5 (data not shown). At E10.5, nuclei with
strong p21 signals were readily observed in endocardial/mesenchymal cells of mutant AV cushions but not in controls,
though cells with cytoplasmic p21 were also observed in control
samples (Figs. 8I, J). We next immunostained sections of mutant
and control embryos with an antibody recognizing cyclin D1,
which was demonstrated previously to regulate TGFβ-mediated
mesenchymal cell proliferation in mouse embryos (Ito et al.,
2003). As shown in Figs. 8K–N, the total intensity of cyclin D1
fluorescent signals, which reflects the protein level of cyclin D1,
appears to be dramatically reduced in Tie1-Cre;Alk3loxp/loxp
embryonic hearts. Quantification analysis revealed a significant
reduction in the percentage of endocardial/mesenchymal cells
with nuclear localized cyclin D1 in cko samples (Fig. 8O).
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Accumulated evidence has indicated that BMP signaling
plays critical roles during AV cushion morphogenesis. In this
study, we performed a detailed characterization of the AV
cushion defects of Tie1-Cre;Alk3loxp/loxp mouse embryos. Using
this endothelial Cre line, we show that inactivation of Alk3,
which encodes a BMP specific type I receptor, impairs EMTand
results in the failure of cellularization of AV cushions thus
documenting an essential function of Alk3 during mesenchymal
cell formation. This work quantitatively demonstrates the extent
to which EMT is impaired by endothelial depletion of Alk3 both
in vivo and in vitro using explant assays. Moreover, we show,
for the first time, that Alk3 is required for normal proliferation
and survival of AV cushion mesenchymal cells. Interestingly,
another report focused primarily on characterization of Nkx2.5-
Cre;Bmp2loxp/loxp embryonic hearts, showing that endocardial
inactivation of Alk3 using a Tie2-Cre line causes defective
EMT in AV cushions (Fig. 4 of Ma et al., 2005), providing
independent confirmation of our observations.
EMT is a critical step regulating initial cushion
morphogenesis. The severely impaired EMT plays the
major role in producing the hypoplastic cushion phenotype
of Tie1-cre;Alk3loxp/loxp embryonic hearts, as the number of
mesenchymal cells formed in these hearts drops to only
∼20% of the normal level from both in vitro culture studies
(Fig. 4) and in vivo section studies (Fig. 3). Bmp2/4 are the
two major BMP molecules expressed in the AVC region
during EMT (Abdelwahid et al., 2001; Ikeda et al., 1996;
Jiao et al., 2003; Jones et al., 1991; Ma et al., 2005; Sugi et
al., 2004). While deletion of Bmp4 in the myocardium does not
cause any observable EMT defects (Jiao et al., 2003), myocardial
inactivation of Bmp2 blocks EMT (Ma et al., 2005; Rivera-
Feliciano and Tabin, 2006), indicating that Bmp2 is the major
BMP ligand released from the myocardium to activate the BMP
signal cascade in endocardial cells for transformation.
We did not observe any differential defects in EMT between
the superior and inferior AV cushions of Tie1-Cre;Alk3loxp/loxp
embryonic hearts. This result differs from the study of Tie2-
Cre;Alk2loxp/loxp embryos; endocardial inactivation of Alk2
preferentially impairs the formation of mesenchymal cells in the
superior cushion, but has a moderate effect on the inferior
cushion (Wang et al., 2005). Thus, endocardial Alk3 is essential
for EMT in both the superior and inferior cushions, and its
functions cannot be fully compensated by Alk2. Since
endocardial depletion of neither gene completely blocks EMT,
Alk2 and Alk3 are likely to play partially redundant roles during
mesenchymal cell formation. An intriguing question that
remains to be addressed is how Alk2 and Alk3-mediated
signaling pathways interact and cooperate with each other to
regulate EMT, especially in the inferior AV cushion.
Smad proteins are direct downstream mediators of TGFβ/
BMP signals (de Caestecker, 2004; Massague et al., 2005; Shi
and Massague, 2003). Consistent with previous reports that
Alk3 specifically mediates BMP signaling, endocardial inacti-
vation of Alk3 reduces phosphorylation (activation) of BMP
Smads (Smad1,5,8) but has little effect on activation of TGFβSmads (Smad2,3) (Fig. 7). The extent of reduction of activated
Smad1,5,8 in Tie1cre;Alk3loxp/loxp embryos (∼95% in controls
vs. ∼60% in mutants) is comparable to the previous report on
Tie2cre;Alk3loxp/loxp embryos (Ma et al., 2005). The presence
of cells with activated BMP Smads is likely due to the
complementation by other type I receptors. Our result suggests
that reducing BMP Smads can sufficiently block most EMT
(>80%). It is currently unclear whether the moderate reduction
of activated BMP Smads can solely account for the robust
reduction of EMT in Tie1-Cre;Alk3loxp/loxp embryos. It is
possible that other Smad-independent pathways, such as MAPK
pathways (Moustakas and Heldin, 2005, and ref. therein), may
also be involved in activating EMT of endocardial cells of the
AVC region.
Significantly increased cell apoptosis and decreased cell
proliferation rate in AV cushion mesenchymal cells of Tie1
Cre;Alk3loxp/loxp embryonic hearts were initially observed from
E10.5, and would thus subsequently enhance the hypoplastic
AV cushion defect. p21 is a universal CDK inhibitor that
blocks cell-cycle progression when present in nuclei
(Coqueret, 2003; Gartel and Tyner, 2002; Semczuk and
Jakowicki, 2004; Swanton, 2004). Though it is generally
thought that cytoplasmic p21 inhibits p53 induced apoptosis
(ibid.), it is well documented that nuclear p21 may also
promote apoptosis through activation of Caspase 3 in various
cell lines, including human endothelial cells (e.g. Gartel, 2005;
Gartel and Tyner, 2002; Nuntharatanapong et al., 2005). p21
positive nuclei in Tie1cre;Alk3loxp/loxp AV cushions were
initially detected at E10.5, coincident with the appearance of
apoptotic cells and an observed reduction of cell proliferation
rate. We speculate that the presence of p21 positive nuclei at
least partially contributes to the abnormal growth/survival of
cushion cells in mutant hearts. Cyclin D1 is a member of the
family of D cyclins which serves as an important positive cell-
cycle regulator. The nuclear localized cyclin D1 promotes cell-
cycle progression through regulating Rb phosphorylation,
while the cytoplasmic cyclin D1 is nonfunctional and is
targeted for proteolysis (Alt et al., 2000; Sherr and Roberts,
1999). Cytoplasmic D1 sequestration serves as an important
regulatory mechanism controlling cell proliferation, survival
and fate determination (e.g. Sumrejkanchanakij et al., 2003;
Tamamori-Adachi et al., 2003). We have shown in this study
that endocardial/mesenchymal Alk3 is required for both the
total expression level and the nuclear localization of cyclin D1
in AV cushion mesenchymal cells. Therefore, cyclin D1 may
be an important regulatory target of Alk3 for controlling the
proper growth/survival of cushion mesenchymal cells. In
addition to the defects of cushion mesenchymal cells, we also
observed cell death in the endothelial wall of blood vessels
(Fig. 5) and blood cell leakage (Fig. 2). Currently, we cannot
exclude the possibility that the cushion mesenchymal cell
defects are secondary to endothelial abnormalities of other
regions of mutant embryos. We favor the explanation that Alk3
can directly act on AV cushion mesenchymal cells based on
the continuous expression of Alk3 in at least some of AV
cushion mesenchymal cells of E11.5 embryos and the
reduction of activated BMP Smads in mesenchymal cells.
285L. Song et al. / Developmental Biology 301 (2007) 276–286In summary, we conclude from our study of Tie1-Cre;Alk3-
embryonic hearts that Alk3-mediated BMP signaling plays
central roles during mouse AV cushion morphogenesis. We
provide quantitative evidence documenting that Alk3 is required
for EMT of AV cushion endocardial cells. Furthermore, we
show for the first time that the function(s) of Alk3 is not limited
to the initial stage of cushion formation (EMT). Rather, Alk3
also plays important roles, directly or indirectly, to promote
proliferation and survival of cushion mesenchymal cells after
they are formed, and that these “late” functions of Alk3 are
mediated through regulating expression and subcellular locali-
zation of both negative (e.g. p21) and positive (e.g. cyclin D1)
cell-cycle regulators. This information may contribute to our
understanding of the molecular and cellular basis of CHDs
involving AV cushion morphogenesis.
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